Cargando…

Characterization of impurities in cefpodoxime proxetil using LC–MS(n)

Reversed-phase liquid chromatography coupled with electrospray ionization tandem mass spectrometry (ESI-MS/MS) was used to characterize impurities in cefpodoxime proxetil, an ester-modified prodrug. Based on the mechanisms by which cephalosporins are degraded, stress tests were designed and performe...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jin, Zhang, Dousheng, Hu, Changqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629086/
https://www.ncbi.nlm.nih.gov/pubmed/26579402
http://dx.doi.org/10.1016/j.apsb.2014.06.007
_version_ 1782398524793552896
author Li, Jin
Zhang, Dousheng
Hu, Changqin
author_facet Li, Jin
Zhang, Dousheng
Hu, Changqin
author_sort Li, Jin
collection PubMed
description Reversed-phase liquid chromatography coupled with electrospray ionization tandem mass spectrometry (ESI-MS/MS) was used to characterize impurities in cefpodoxime proxetil, an ester-modified prodrug. Based on the mechanisms by which cephalosporins are degraded, stress tests were designed and performed. The bulk material and capsule were eluted through a C18 column with formic acid–methanol–water as the mobile phase. In total, 15 impurities were characterized in commercial samples, including 7 known impurities and 8 new impurities. The structures of these unknown compounds were deduced via comparison with the fragmentation patterns of cefpodoxime proxetil. Data from this systematic study will help improve the safety and quality of cefpodoxime proxetil.
format Online
Article
Text
id pubmed-4629086
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-46290862015-11-17 Characterization of impurities in cefpodoxime proxetil using LC–MS(n) Li, Jin Zhang, Dousheng Hu, Changqin Acta Pharm Sin B Original Article Reversed-phase liquid chromatography coupled with electrospray ionization tandem mass spectrometry (ESI-MS/MS) was used to characterize impurities in cefpodoxime proxetil, an ester-modified prodrug. Based on the mechanisms by which cephalosporins are degraded, stress tests were designed and performed. The bulk material and capsule were eluted through a C18 column with formic acid–methanol–water as the mobile phase. In total, 15 impurities were characterized in commercial samples, including 7 known impurities and 8 new impurities. The structures of these unknown compounds were deduced via comparison with the fragmentation patterns of cefpodoxime proxetil. Data from this systematic study will help improve the safety and quality of cefpodoxime proxetil. Elsevier 2014-08 2014-07-14 /pmc/articles/PMC4629086/ /pubmed/26579402 http://dx.doi.org/10.1016/j.apsb.2014.06.007 Text en © 2014 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Original Article
Li, Jin
Zhang, Dousheng
Hu, Changqin
Characterization of impurities in cefpodoxime proxetil using LC–MS(n)
title Characterization of impurities in cefpodoxime proxetil using LC–MS(n)
title_full Characterization of impurities in cefpodoxime proxetil using LC–MS(n)
title_fullStr Characterization of impurities in cefpodoxime proxetil using LC–MS(n)
title_full_unstemmed Characterization of impurities in cefpodoxime proxetil using LC–MS(n)
title_short Characterization of impurities in cefpodoxime proxetil using LC–MS(n)
title_sort characterization of impurities in cefpodoxime proxetil using lc–ms(n)
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629086/
https://www.ncbi.nlm.nih.gov/pubmed/26579402
http://dx.doi.org/10.1016/j.apsb.2014.06.007
work_keys_str_mv AT lijin characterizationofimpuritiesincefpodoximeproxetilusinglcmsn
AT zhangdousheng characterizationofimpuritiesincefpodoximeproxetilusinglcmsn
AT huchangqin characterizationofimpuritiesincefpodoximeproxetilusinglcmsn